Retatrutide 20mg – Triple Agonist Research Peptide | Tides Lab

Retatrutide is a novel triple agonist peptide targeting the GLP-1, GIP and glucagon receptors, making it one of the most mechanistically advanced compounds currently under metabolic research investigation.

This 20mg lyophilised formulation is supplied at 99% purity and intended strictly for laboratory research purposes.

Key Features

• 20mg lyophilised Retatrutide

• Triple receptor agonist (GLP-1 / GIP / Glucagon)

• ≥99% purity

• Research use only

• Discreet Australian shipping

Mechanism Overview

Retatrutide’s triple agonism differentiates it from single GLP-1 receptor agonists. By simultaneously interacting with GLP-1, GIP and glucagon receptors, it is being studied for its metabolic signalling effects.

For a detailed breakdown of how triple agonists function, see our
→ GLP-1 Peptides for Weight Loss (Mechanism Deep Dive)
→ Best Peptide for Weight Loss Comparison Guide

Research Use Only

This compound is supplied for laboratory research and analytical purposes only. Not for human consumption.